J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 8,700.00
+450.00 (5.45%)
At close: Oct 16, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 50.87 billion as of October 16, 2026. It is the 32,705th most valuable company in the world and the 1,842nd biggest in South Korea. Its market cap has decreased by 3.76% in one year.
Market Cap
50.87B
Enterprise Value
42.01B
Revenue
43.90B
Global Rank
Country Rank
#1,842 South Korea
PE Ratio
8.75
ChartMarket Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 50.87B, a decrease of -64.90%. That is a compound annual growth rate of -33.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 50.87B | 1.16% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PanGen Biotech | 64.26B |
| ABION | 60.91B |
| NovMetaPharma | 58.69B |
| ADBiotech | 58.08B |
| Psomagen | 56.36B |
| TegoScience | 55.09B |
| KoBioLabs | 53.40B |
| QuadMedicine | 50.58B |